1 497

Cited 9 times in

Antiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells

DC Field Value Language
dc.contributor.author강석민-
dc.contributor.author권혁문-
dc.contributor.author이경혜-
dc.contributor.author임소연-
dc.contributor.author조홍근-
dc.contributor.author황기철-
dc.date.accessioned2015-07-14T16:46:34Z-
dc.date.available2015-07-14T16:46:34Z-
dc.date.issued2004-
dc.identifier.issn0014-2999-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/111565-
dc.description.abstractReactive oxygen species-mediated cellular injury is involved in the pathogenesis of many diseases, including those affecting the cardiovascular system, such as myocardial ischemia-reperfusion injury, inflammation, and atheroscleosis. Raxofelast (IRFI-016; (+/-)-5-acetoxy-2, 3-dihydro-4, 6, 7-trimethyl-2-benzofuran-acetic acid) was designed with the aim of maximizing the antioxidant potency of phenols chemically related to vitamin E. The antioxidant activity of raxofelast has been convincingly demonstrated in several in vitro studies and in various models of ischemia-reperfusion injury. In this study, the antiproliferative effects of raxofelast were investigated to determine whether transduction signals and protooncogenes are affected in H(2)O(2)-stimulated rat aortic smooth muscle cells. In a tetrazolium-based colorimetric assay, the proliferation of rat aortic smooth muscle cells was increased by 3-fold in 0.1% fetal bovine serum/Dulbecco's modified Eagle's medium (DMEM) containing 500 microM H(2)O(2), indicating that exogenous 500 microM H(2)O(2) was a growth stimulator of rat aortic smooth muscle cells. Exogenous H(2)O(2) significantly activated extracellular signal-regulated kinases (ERKs) activity within 30 min and raxofelast inhibited the ERKs activation dose dependently in 500 microM H(2)O(2)-stimulated rat aortic smooth muscle cells (IC(50): 200 microM). Raxofelast reduced the intracellular reactive oxygen species generated by exogenous H(2)O(2) in a dose-dependent manner. In 500 microM H(2)O(2)-stimulated rat aortic smooth muscle cells, raxofelast dramatically attenuated the activation of mitogen-activating protein kinase (MAPK)/ERK kinase 1, 2 (MEK1,2) and protein kinase C (PKC) without affecting Ras expression. Induction of c-myc mRNA was significantly reduced dose dependently up to 100 microM by raxofelast in concentrations. These data indicate that the antiproliferative effects of raxofelast in H(2)O(2)-stimulated rat aortic smooth muscle cells may involve the suppression of intracellular reactive oxygen species formation and the inhibition of ERKs by inactivation through PKC and MEK1,2 and down-regulation of c-myc expression, regardless of Ras activation.-
dc.description.statementOfResponsibilityopen-
dc.format.extent119~125-
dc.relation.isPartOfEUROPEAN JOURNAL OF PHARMACOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleAntiproliferative mechanisms of raxofelast (IRFI-016) in H2O2-stimulated rat aortic smooth muscle cells-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentMedical Research Center (임상의학연구센터)-
dc.contributor.googleauthorKyung-Hye Lee-
dc.contributor.googleauthorSoYeon Lim-
dc.contributor.googleauthorKi-Chul Hwang-
dc.contributor.googleauthorYangsoo Jang-
dc.contributor.googleauthorHakbae Lee-
dc.contributor.googleauthorkwang-Hoe Chung-
dc.contributor.googleauthorHyuck Moon Kwon-
dc.contributor.googleauthorJi Hyung Chung-
dc.contributor.googleauthorHong Keun Cho-
dc.contributor.googleauthorDae Hyeok Kim-
dc.contributor.googleauthorSeok-Min Kang-
dc.identifier.doi10.1016/j.ejphar.2003.11.012-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.relation.journalcodeJ00842-
dc.identifier.eissn1879-0712-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0014299903026426-
dc.subject.keywordRaxofelast-
dc.subject.keywordAnti-proliferation-
dc.subject.keywordReactive oxygen species-
dc.subject.keywordSmooth muscle cell-
dc.contributor.alternativeNameKang, Seok Min-
dc.contributor.alternativeNameKwon, Hyuck Moon-
dc.contributor.alternativeNameLee, Kyung Hye-
dc.contributor.alternativeNameLim, So Yeon-
dc.contributor.alternativeNameCho, Hong Keun-
dc.contributor.alternativeNameHwang, Ki Chul-
dc.rights.accessRightsnot free-
dc.citation.volume484-
dc.citation.number2-3-
dc.citation.startPage119-
dc.citation.endPage125-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF PHARMACOLOGY, Vol.484(2-3) : 119-125, 2004-
dc.identifier.rimsid34923-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.